EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomarkers of Neurodegeneration and Alzheimer’s Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study

Allison L B Shapiro iD, Christina Coughlan iD, Brianne M Bettcher, Meghan E Pauley iD, Jeongchul Kim, Petter Bjornstad, Benjamin Rajic, Jennifer Truong iD, Christopher Bell, Ye Ji Choi iD, Keenan A Walker iD, Huntington Potter iD und 3 weitere

Endocrines · 06.05.2024 · 5 (2) · 197-213

DOI: 10.3390/endocrines5020014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrines, online erschienen am 06.05.2024. Verfasst von Allison L B Shapiro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado at Anschutz (CU-Anschutz), Aurora, CO 80045, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCCDPHP CDC HHS, ACL HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adult-onset diabetes increases one’s risk of neurodegenerative disease including Alzheimer’s disease (AD); however, the risk associated with youth-onset diabetes (Y-DM) remains underexplored. We quantified plasma biomarkers of neurodegeneration and AD in participants with Y-DM from the SEARCH cohort at adolescence and young adulthood (Type 1, n = 25; Type 2, n = 25; 59% female; adolescence, age = 15 y/o [2.6]; adulthood, age = 27.4 y/o [2.2]), comparing them with controls (adolescence, n = 25, age = 14.8 y/o [2.7]; adulthood, n = 21, age = 24.9 y/o [2.8]). Plasma biomarkers, including glial fibrillary acidic protein (GFAP), neurofilament light chain protein (NfL), phosphorylated tau-181 (pTau181), and amyloid beta (Aβ40, Aβ42), were measured via Simoa. A subset of participants (n = 7; age = 27.5 y/o [5.7]) and six controls (age = 25.1 y/o [4.5]) underwent PET scans to quantify brain amyloid and tau densities in AD sensitive brain regions. Y-DM adolescents exhibited lower plasma levels of Aβ40, Aβ42, and GFAP, and higher pTau181 compared to controls (p < 0.05), a pattern persisting into adulthood (p < 0.001). All biomarkers showed significant increases from adolescence to adulthood in Y-DM (p < 0.01), though no significant differences in brain amyloid or tau were noted between Y-DM and controls in adulthood. Preliminary evidence suggests that preclinical AD neuropathology is present in young people with Y-DM, indicating a potential increased risk of neurodegenerative diseases.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloidneurodegenerationplasma biomarkerstauyouth-onset diabetes

Autor:innen und Institutionen

  • Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado at Anschutz (CU-Anschutz), Aurora, CO 80045, USA.
  • Section of Endocrinology, Department of Pediatrics, School of Medicine (SOM), CU-Anschutz, Aurora, CO 80045, USA.
  • University of Colorado Alzheimer's and Cognition Center, CU-Anschutz, Aurora, CO 80045, USA.
  • Department of Neurology, SOM, CU-Anschutz, Aurora, CO 80045, USA.
  • Barbara Davis Center for Diabetes, CU-Anschutz, Aurora, CO 80045, USA.
  • Radiology Informatics and Image Processing Laboratory, Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.

ORCID-Profile: Allison L B Shapiro, Christina Coughlan, Meghan E Pauley, Jennifer Truong, Ye Ji Choi, Keenan A Walker, Huntington Potter

Förderung

  • NIDDK NIH HHS
  • NCCDPHP CDC HHS
  • ACL HHS
  • HSRD VA
  • American College of Radiology (ACR) Fund
  • Centers for Disease Control and Prevention
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Shapiro, A. L. B., Coughlan, C., Bettcher, B. M., Pauley, M. E., Kim, J., Bjornstad, P., Rajic, B., Truong, J., Bell, C., Choi, Y. J., Walker, K. A., Potter, H., Liese, A. D., Dabelea, D., & Whitlow, C. T. (2024). Biomarkers of Neurodegeneration and Alzheimer’s Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study. Endocrines, 5(2), 197-213. https://doi.org/10.3390/endocrines5020014

Vancouver

Shapiro ALB, Coughlan C, Bettcher BM, Pauley ME, Kim J, Bjornstad P, et al. Biomarkers of Neurodegeneration and Alzheimer’s Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study. Endocrines. 2024;5(2):197-213. doi:10.3390/endocrines5020014

BibTeX
@article{Shapiro2024,
  author = {Shapiro, Allison L B and Coughlan, Christina and Bettcher, Brianne M and Pauley, Meghan E and Kim, Jeongchul and Bjornstad, Petter and Rajic, Benjamin and Truong, Jennifer and Bell, Christopher and Choi, Ye Ji and Walker, Keenan A and Potter, Huntington and Liese, Angela D and Dabelea, Dana and Whitlow, Christopher T},
  title = {Biomarkers of Neurodegeneration and Alzheimer’s Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study},
  journal = {Endocrines},
  year = {2024},
  volume = {5},
  number = {2},
  pages = {197--213},
  doi = {10.3390/endocrines5020014}
}
Kostenlos starten →